Jože Colaric
Chief Executive Officer bij KRKA, D. D.
Profiel
Jože Colaric is currently the Chairman-Management Board & CEO at KRKA dd since 2005 and the Chairman & Chief Executive Officer at KRKA Farmaceutici Milano SRL since 2004.
He completed his undergraduate degree at the University of Ljubljana in 1979.
Actieve functies van Jože Colaric
| Bedrijven | Functie | Begin |
|---|---|---|
| KRKA, D. D. | Chief Executive Officer | 01-01-2005 |
KRKA Farmaceutici Milano SRL
 KRKA Farmaceutici Milano SRL Pharmaceuticals: MajorHealth Technology Part of KRKA dd, KRKA Farmaceutici Milano SRL is a leading Italian generic pharmaceutical company with nearly 70 years of experience. The private company is based in Milan, Italy. We use modern technologies and our own analytical methods to develop and produce new pharmaceutical forms and strengths. Every day more than 12,000 employees work on the quality, innovation and development of pharmaceutical products. By focusing on patient needs and requirements, our innovations facilitate treatment and improve patient adherence and therapy outcomes. The company was founded in 1954. Jože Colaric has been the CEO of the company since 2004. | Chief Executive Officer | 12-07-2004 |
Opleiding van Jože Colaric
| University of Ljubljana | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| KRKA, D. D. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
KRKA Farmaceutici Milano SRL
KRKA Farmaceutici Milano SRL Pharmaceuticals: MajorHealth Technology Part of KRKA dd, KRKA Farmaceutici Milano SRL is a leading Italian generic pharmaceutical company with nearly 70 years of experience. The private company is based in Milan, Italy. We use modern technologies and our own analytical methods to develop and produce new pharmaceutical forms and strengths. Every day more than 12,000 employees work on the quality, innovation and development of pharmaceutical products. By focusing on patient needs and requirements, our innovations facilitate treatment and improve patient adherence and therapy outcomes. The company was founded in 1954. Jože Colaric has been the CEO of the company since 2004. | Health Technology |
